Health Care & Life Sciences » Medical Equipment & Supplies | Ypsomed Holding AG

Ypsomed Holding AG | Income Statement

Fiscal year is April-March. All values CHF Thousands.
2014
2015
2016
2017
2018
2019
Sales/Revenue
276,257.00
306,632.00
336,922.00
389,555.00
466,119.00
453,765
Cost of Goods Sold (COGS) incl. D&A
184,197.00
194,836.00
209,066.00
236,377.00
288,767.00
259,653
Gross Income
92,060.00
111,796.00
127,856.00
153,178.00
177,352.00
194,112
SG&A Expense
76,947.00
86,155.00
86,869.00
100,574.00
119,627.00
127,784
EBIT
12,119.00
24,026.00
42,706.00
54,380.00
57,725.00
66,328
Unusual Expense
593.00
2,933.00
2,159.00
401.00
149.00
1,317
Non Operating Income/Expense
3,618.00
3,545.00
3,250.00
1,081.00
5,031.00
5,667
Interest Expense
1,115.00
920.00
606.00
478.00
656.00
824
Pretax Income
15,243.00
23,733.00
43,197.00
55,390.00
61,951.00
69,880
Income Tax
1,635.00
4,338.00
7,385.00
9,143.00
9,891.00
9,744
Consolidated Net Income
13,608.00
19,395.00
35,812.00
46,247.00
52,060.00
60,136
Net Income
13,608.00
19,395.00
35,812.00
46,247.00
52,060.00
60,136
Net Income After Extraordinaries
13,608.00
19,395.00
35,812.00
46,247.00
52,060.00
60,136
Net Income Available to Common
13,608.00
19,395.00
35,812.00
46,247.00
52,060.00
60,136
EPS (Basic)
1.08
1.54
2.84
3.67
4.14
4.77
Basic Shares Outstanding
12,614.70
12,624.60
12,624.90
12,613.90
12,586.60
12,603
EPS (Diluted)
1.08
1.54
2.84
3.67
4.14
4.77
Diluted Shares Outstanding
12,614.70
12,624.60
12,624.90
12,613.90
12,586.60
12,603
EBITDA
36,649.00
50,102.00
69,823.00
85,069.00
92,194.00
111,216
Other Operating Expense
2,994.00
1,615.00
1,719.00
1,776.00
-
-
Non-Operating Interest Income
28.00
15.00
6.00
6.00
-
26

About Ypsomed Holding

View Profile
Address
Brunnmattstrasse 6
Burgdorf Bern (Berne) 3401
Switzerland
Employees -
Website http://www.ypsomed.com
Updated 07/08/2019
Ypsomed Holding AG engages in the development and manufacture of injection systems for self-medication of drugs by patients, most notably used to treat diabetes. Its products include DiaExpert, BGMS, OmniPod, YpsoPump & Orbit, Pen needles, Injection systems, and Contract manufacturing. The company operates through the following business segments: Ypsomed Diabetes Care, Ypsomed Delivery Systems.

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.